Depletion of these cells strongly impaired the effect of the ENO1‐DNA vaccine in limiting tumour growth and improving survival in IL17A‐deficient mice, while in IL17A+/+ mice, the role of CD4+ T cells was much more crucial. Here, ENO1 is linked to neoplasm.